Parakeet Health Closes $10M Series A Round

Parakeet Health has raised $10 million in a Series A funding round, according to FinSMEs.

The round marks the company's transition from early-stage backing to growth capital. FinSMEs, which first reported the transaction, did not disclose the lead investor, the composition of the syndicate, or the valuation attached to the deal.

Series A financing of this size typically funds product development, hiring, and market expansion for venture-backed startups. FinSMEs reported no breakdown of how Parakeet Health intends to deploy the capital, and the company has not yet published details of its revenue base or customer footprint.

The $10 million figure is the single confirmed deal term in the announcement. FinSMEs listed no participating investors by name and quoted no executives from the company.

FinSMEs also did not specify the date on which the round closed, the jurisdiction of incorporation, or prior funding raised by the company.

For the digital health sector, a $10 million Series A sits within the conventional range for companies moving from seed-stage validation toward commercial scale. Investors in the category have continued to fund startups at this stage even as overall venture activity has tightened, though FinSMEs offered no market context with the announcement.

The company's next disclosed milestones — customer numbers, revenue, or a named Series B process — will determine whether the round becomes a stepping stone or a ceiling.